About Us
Mass Spec Technologies is a pioneering force in the clinical laboratory industry, with deep-rooted expertise in CLIA-certified environments. For years, we have specialized in the development and launch of high-performing molecular diagnostic laboratories, successfully bringing online more than 40 new CLIA-compliant labs across the United States each year. This extensive track record has positioned us as trusted partners to lab operators, healthcare providers, and innovators nationwide, helping to expand access to advanced testing while navigating the complexities of regulatory compliance, operational scaling, and quality assurance.
Building on this foundation of proven success in traditional lab infrastructure, we are now leading the transformation of the molecular diagnostics space through the integration of cutting-edge artificial intelligence. At the heart of our mission is the creation of an intelligent, AI-powered ecosystem that enhances every aspect of laboratory workflows—from sample processing and molecular amplification to data interpretation and clinical reporting.
Our innovations include:
- Custom software development: Tailored Laboratory Information Systems (LIS) and AI-driven analytics platforms designed specifically for CLIA labs. These solutions automate complex processes, provide real-time insights, predict trends, and ensure seamless compliance with evolving regulations.
- In-house engineering of advanced hardware: Next-generation PCR machines and molecular diagnostic instruments engineered with embedded AI capabilities. Our proprietary designs optimize amplification protocols, improve accuracy through machine learning-based curve analysis, enable predictive maintenance, and integrate directly with our software ecosystem for end-to-end automation.
- The largest CLIA Licensed Laboratory development service: across the United States with expertise and strong partnership
We combine decades of hands-on CLIA lab experience with forward-thinking AI technology to address the real-world challenges faced by modern laboratories: rising test volumes, workforce constraints, the demand for faster and more precise results, and the shift toward precision medicine. Our ecosystem empowers CLIA labs to operate more efficiently, reduce errors, accelerate turnaround times, and deliver higher-value diagnostics that directly impact patient care.
Headquartered with a national footprint, we remain committed to supporting the growth of the U.S. clinical laboratory landscape—whether by launching new facilities or modernizing existing ones with AI intelligence. At Mass Spec Technologies, we don't just build labs or machines; we build the future of molecular diagnostics, where human expertise and artificial intelligence work in harmony to advance healthcare.
Join us in redefining what's possible in the molecular space. Contact us to learn how our experience and innovations can elevate your laboratory operations.